Correlation Between Radiation Dose to 18F-FDG-PET Defined Active Bone Marrow Subregions and Acute Hematologic Toxicity in Cervical Cancer Patients Treated With Chemoradiotherapy

被引:119
作者
Rose, Brent S. [2 ]
Liang, Yun [2 ]
Lau, Steven K. [2 ]
Jensen, Lindsay G. [2 ]
Yashar, Catheryn M. [2 ]
Hoh, Carl K. [3 ]
Mell, Loren K. [1 ,2 ]
机构
[1] Univ Calif San Diego, Moores Canc Ctr, Dept Radiat Oncol, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Rebecca & John Moores Comprehens Canc Ctr, Ctr Adv Radiotherapy Technol, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Div Nucl Med, La Jolla, CA 92093 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2012年 / 83卷 / 04期
关键词
Cervical cancer; Hematologic toxicity; Bone marrow; F-18-fluorodeoxyglucose positron emission tomography; INTENSITY-MODULATED RADIOTHERAPY; CONCURRENT CISPLATIN; PELVIC RADIOTHERAPY; RANDOMIZED-TRIAL; ONCOLOGY-GROUP; THERAPY; CHEMOTHERAPY; CHEMORADIATION; PREDICTORS; CARCINOMA;
D O I
10.1016/j.ijrobp.2011.09.048
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To test the hypothesis that radiation dose to F-18-fluorodeoxyglucose positron emission tomography (F-18-FDG-PET)-defined active bone marrow (BMACT) subregions is correlated with hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Methods and Materials: The conditions of 26 women with cervical cancer who underwent F-18-FDG-PET before treatment with concurrent cisplatin and intensity-modulated radiation therapy were analyzed. BMACT was defined as the subregion of total bone marrow (BMTOT) with a standardized uptake value (SUV) equal to or above the mean for that individual. Inactive bone marrow (BMINACT) was defined as BMTOT - BMACT. Generalized linear modeling was used to test the correlation between BMACT and BMINACT dose-volume metrics and hematologic nadirs, particularly white blood cell count (WBC) and absolute neutrophil count (ANC). Results: Increased BMACT mean dose was significantly associated with decreased log(WBC) nadir (beta = -0.04; 95% CI, -0.07to -0.01; p = 0.009), decreased log(ANC) nadir (beta = -0.05; 95% CI, -0.08 to -0.02; p = 0.006), decreased hemoglobin nadir (beta = -0.16; 95% CI, 0.27 to 0.05; p = 0.010), and decreased platelet nadir (beta = 6.16; 95% CI, 9.37 to -2.96; p < 0.001). By contrast, there was no association between BMINACT mean dose and log(WBC) nadir (beta = -0.01; 95% CI, -0.06 to 0.05; p = 0.84), log(ANC) nadir (beta = -0.03; 95% CI, -0.10 to 0.04; p = 0.40), hemoglobin nadir (beta = -0.09; 95% CI, -0.31 to 0.14; p = 0.452), or platelet nadir (beta = -3.47; 95% CI, -10.44 to 3.50; p = 0.339). Conclusions: Irradiation of BM subregions with higher F-18-FDG-PET activity was associated with hematologic toxicity, supporting the hypothesis that reducing dose to BMACT subregions could mitigate hematologic toxicity. Future investigation should seek to confirm these findings and to identify optimal SUV thresholds to define BMACT. (C) 2012 Elsevier Inc.
引用
收藏
页码:1185 / 1191
页数:7
相关论文
共 20 条
  • [1] Compliance with and acute hematologic toxic effects of chemoradiation in indigent women with cervical cancer
    Abu-Rustum, NR
    Lee, S
    Correa, A
    Massad, LS
    [J]. GYNECOLOGIC ONCOLOGY, 2001, 81 (01) : 88 - 91
  • [2] RADIATION-RELATED PREDICTORS OF HEMATOLOGIC TOXICITY AFTER CONCURRENT CHEMORADIATION FOR CERVICAL CANCER AND IMPLICATIONS FOR BONE MARROW-SPARING PELVIC IMRT
    Albuquerque, Kevin
    Giangreco, David
    Morrison, Courtney
    Siddiqui, Mohammed
    Sinacore, Jim
    Potkul, Ronald
    Roeske, John
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (04): : 1043 - 1047
  • [3] Structural and functional imaging of normal bone marrow and evaluation of its age-related changes
    Blebea, Judy S.
    Houseni, Mohamed
    Torigian, Drew A.
    Fan, Chengzhong
    Mavi, Ayse
    Zhuge, Ying
    Iwanaga, Tad
    Mishra, Shipra
    Udupa, Jay
    Zhuang, Jiyuan
    Gopal, Rohit
    Alavi, Abass
    [J]. SEMINARS IN NUCLEAR MEDICINE, 2007, 37 (03) : 185 - 194
  • [4] FEMALE PELVIC BONE-MARROW - SERIAL MR-IMAGING BEFORE, DURING, AND AFTER RADIATION-THERAPY
    BLOMLIE, V
    ROFSTAD, EK
    SKJONSBERG, A
    TVERA, K
    LIEN, HH
    [J]. RADIOLOGY, 1995, 194 (02) : 537 - 543
  • [5] TOXICITY CRITERIA OF THE RADIATION-THERAPY ONCOLOGY GROUP (RTOG) AND THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER (EORTC)
    COX, JD
    STETZ, J
    PAJAK, TF
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (05): : 1341 - 1346
  • [6] Phase III, Open-Label, Randomized Study Comparing Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Patients With Stage IIB to IVA Carcinoma of the Cervix
    Duenas-Gonzalez, Alfonso
    Zarba, Juan J.
    Patel, Firuza
    Alcedo, Juan C.
    Beslija, Semir
    Casanova, Luis
    Pattaranutaporn, Pittayapoom
    Hameed, Shahid
    Blair, Julie M.
    Barraclough, Helen
    Orlando, Mauro
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (13) : 1678 - 1685
  • [7] Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis
    Green, JA
    Kirwan, JM
    Tierney, JF
    Symonds, P
    Fresco, L
    Collingwood, M
    Williams, CJ
    [J]. LANCET, 2001, 358 (9284) : 781 - 786
  • [8] DISTRIBUTION OF PROLIFERATING BONE MARROW IN ADULT CANCER PATIENTS DETERMINED USING FLT-PET IMAGING
    Hayman, James A.
    Callahan, Jason W.
    Herschtal, Alan
    Everitt, Sarah
    Binns, David S.
    Hicks, Rod J.
    Mac Manus, Michael
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (03): : 847 - 852
  • [9] Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group
    Keys, HM
    Bundy, BN
    Stehman, FB
    Okagaki, T
    Gallup, DG
    Burnett, AF
    Rotman, MZ
    Fowler, WC
    [J]. GYNECOLOGIC ONCOLOGY, 2003, 89 (03) : 343 - 353
  • [10] IMPACT OF BONE MARROW RADIATION DOSE ON ACUTE HEMATOLOGIC TOXICITY IN CERVICAL CANCER: PRINCIPAL COMPONENT ANALYSIS ON HIGH DIMENSIONAL DATA
    Liang, Yun
    Messer, Karen
    Rose, Brent S.
    Lewis, John H.
    Jiang, Steve B.
    Yashar, Catheryn M.
    Mundt, Arno J.
    Mell, Loren K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : 912 - 919